Skip to main content
Clinical Trials/NCT05685693
NCT05685693Active, not recruitingNot Applicable

The Effect of ROSA®-Assisted Knee Arthroplasty on Clinical Outcomes

Zuyderland Medisch Centrum1 site in 1 country150 target enrollmentStarted: December 16, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
Oxford Knee Score

Study Overview

Brief Summary

This is a randomized clinical study, in which 150 patients with end-stage osteoarthritis will be enrolled to ROSA®-assisted knee arthroplasty or conventional knee arthroplasty. Patients are recruited at Zuyderland Medical Center, enrolled pre-operatively and followed up for 12 months post-surgery. In- and exclusion criteria are stated below.

After recruitment, participants will be invited for a pre-operative visit. During this pre-operative visit Informed Consent is signed and completion of patient-reported outcome measures (PROMs) is checked. Additionally, measurements regarding body composition, strength and fitness and metabolic outcomes are performed. Participants will have a blood sample taken. Scans, adverse event and medication use will be confirmed. Participants will receive a ActiGraph for collecting data from physical activity. Of all patients, 72 will undergo additional measurements (gait, proprioception).

During surgery ROSA- and surgery-data will be collected. Post-operative participants will have a 6-weeks, 3-month and 12-month visit. During these visits pre-operative measurements are repeated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
40 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Eligible for primary TKA
  • age 40-90 years
  • Body-Mass-Index 18.5-50.0 kg/m2
  • American Society of Anaesthesiologists Class I-III
  • Willingness and capability to understand and follow protocol

Exclusion Criteria

  • - Rheuma-/trauma-indicated knee arthroplasty

Arms & Interventions

Conventional TKA

Active Comparator

Conventional TKA, with no patient-specific instrumentation or robotic assistance

Intervention: conventional total knee arthroplasty (Procedure)

Robotic-assisted TKA

Experimental

ROSA Knee System assisted TKA

Intervention: Robotic-assisted total knee arthroplasty (raTKA) (Procedure)

Outcomes

Primary Outcomes

Oxford Knee Score

Time Frame: 12-months post-operative

The Oxford Knee Score (OKS, best to worst 0-48) measures pain intensity and functional limitation of the knee during various activities. The questionnaire consists of 12 items. The maximum total score is 60 and corresponds with the highest pain intensity and functional limitation.

Oxford Knee Score

Time Frame: 3-months post-operative

The Oxford Knee Score (OKS, best to worst 0-48) measures pain intensity and functional limitation of the knee during various activities. The questionnaire consists of 12 items. The maximum total score is 60 and corresponds with the highest pain intensity and functional limitation.

Secondary Outcomes

  • Stability of the knee(Immediately after the surgery)
  • Pain Catastrophizing(Pre-operative, 3-months and 12-months post-operative.)
  • Pain Sensitivity(Pre-operative, 3-months and 12-months post-operative.)
  • Mobility(Pre-operative, 3-months and 12-months post-operative.)
  • Duration of surgery(During surgery)
  • Anesthesia(During surgery)
  • Mobility of the knee(During and immediately after the surgery)
  • Symptoms(Pre-operative, 3-months and 12-months post-operative.)
  • Patient Survival(90-day and 1-year)
  • Physical Activity(Pre-operative, 3-months and 12-months post-operative.)
  • Body composition(Pre-operative, 3-months and 12-months post-operative.)
  • Handgrip strength(Pre-operative, 3-months and 12-months post-operative.)
  • Cost of procedure, implants(During Surgery)
  • Physical strength(Pre-operative, 3-months and 12-months post-operative.)
  • Quality of Life-Index(Pre-operative, 3-months and 12-months post-operative.)
  • Blood loss(During surgery)
  • Length of hospital stay(During in-patient stay for indicated surgery (up to 5 days))
  • Knee implant position(Immediately after the surgery)
  • Implant Survival(90-day and 1-year)
  • Work Productivity and Activity Impairment(Pre-operative, 3-months and 12-months post-operative.)
  • Complications(During in-patient stay for indicated surgery (up to 5 days))
  • Mechanical axis of the leg.(3-months post-surgery)
  • Metabolic Syndrome(Pre-operative, 3-months and 12-months post-operative.)
  • Physical condition(Pre-operative, 3-months and 12-months post-operative.)
  • Cost of procedure, personnel(During Surgery)
  • Productivity(Pre-operative, 3-months and 12-months post-operative.)
  • Medical consumption(Pre-operative, 3-months and 12-months post-operative.)
  • Physical mobility(Pre-operative, 3-months and 12-months post-operative.)
  • Work Ability Index(Pre-operative, 3-months and 12-months post-operative.)

Investigators

Sponsor
Zuyderland Medisch Centrum
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials